Rituximab treatment in non-lupus full-house nephropathy: A case report
Caroline Gee1, Dao Le1, Matthew D Nguyen1
1Division of Nephrology, Hypertension and Kidney Transplantation, University of California, Irvine, CA, USA.
Non-lupus full-house nephropathy, a rare kidney disease, showed positive response to rituximab treatment in a refractory case. This suggests rituximab may be a viable option for this condition.
Area of Science:
- Nephrology
- Immunology
- Pathology
Background:
- Non-lupus full-house nephropathy is characterized by "full-house" immunofluorescence on renal biopsy without lupus markers.
- This rare condition has diverse etiologies and limited established treatment options.
- Existing immunosuppressive therapies show variable efficacy.
More Related Videos
09:43Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Related Concept Videos
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Continuous Renal Replacement Therapy
Chronic Kidney Disease III: Interprofessional Care
